{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:24:37Z","timestamp":1785230677424,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1208\/pt010207","type":"journal-article","created":{"date-parts":[[2004,4,9]],"date-time":"2004-04-09T17:11:21Z","timestamp":1081530681000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Kinetics of pramlintide degradation in aqueous solution as a function of temperature and pH"],"prefix":"10.1208","volume":"1","author":[{"given":"Richard A.","family":"Kenley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Tracht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Stepanenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"L'Italien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,19]]},"reference":[{"key":"121_CR1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/bst0230325","volume":"23","author":"A Young","year":"1995","unstructured":"Young A, Pittner R, Gedulin B, Vine W, Rink T. Amylin. Regulation of carbohydrate metabolism.Biochem Soc Trans. 1995:23:325\u2013331.","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"121_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0029-1211958","volume":"106","author":"WA Scherbaum","year":"1998","unstructured":"Scherbaum WA. The role of amylin in the physiology of glycemic control.Experimental and Clinical Endocrinol and Diabetes.1998:106(2):97\u2013102.","journal-title":"Experimental and Clinical Endocrinol and Diabetes"},{"key":"121_CR3","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0140-6736(93)91153-D","volume":"341","author":"S Amiel","year":"1993","unstructured":"Amiel S. Amylin and diabetes.Lancet. 1993;341:1249\u20131250.","journal-title":"Lancet"},{"issue":"Suppl 2","key":"121_CR4","first-page":"235A","volume":"45","author":"S Janes","year":"1996","unstructured":"Janes S, Gaeta L, Beaumont K, Beeley K, Rink T. The selection of pramlintide for clinical evaluation.Diabetes. 1996;45(Suppl 2): 235A.","journal-title":"Diabetes"},{"issue":"7","key":"121_CR5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/(SICI)1096-9136(199707)14:7<547::AID-DIA390>3.0.CO;2-U","volume":"14","author":"RG Thompson","year":"1997","unstructured":"Thompson RG, Gottlieb A, Organ K. Kolterman OG. Pramlintide, a human amylin analog reduced post-prandial plasma glucose. insulin and c-peptide concentrations in patients with type II diabetes.Diabetic Medicine 1997;14(7):547\u2013555.","journal-title":"Diabetic Medicine"},{"issue":"4","key":"121_CR6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/diabetes.46.4.632","volume":"46","author":"RG Thompson","year":"1997","unstructured":"Thompson RG, Peterson J, Gottlieb A, Mullane J. Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM: results of a multi-center trial.Diabetes. 1997;46(4):632\u2013636.","journal-title":"Diabetes"},{"issue":"10","key":"121_CR7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nbt1097-935","volume":"15","author":"V Brower","year":"1997","unstructured":"Brower V. Amylin's pramlintide best of bad bunch of diabetes drugs.Nature Biotechnol. 1997;15(10):935.","journal-title":"Nature Biotechnol."},{"key":"121_CR8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1023\/A:1011934829263","volume":"15","author":"C Hekman","year":"1998","unstructured":"Hekman C, Demond W, Dixit T, et al. Isolation and identification of peptide degradation products of heat stressed pramlintide injection drug product.Pharm Res. 1998;15:650\u2013659.","journal-title":"Pharm Res."},{"issue":"1","key":"121_CR9","first-page":"6","volume":"1","author":"W Demond","year":"2000","unstructured":"Demond W, Lokensgard D, Kelley P, Herman K, Weilersbacher G, Kenley R. Orthogonal HPLC methods for quantitating related substances and degradation products of pramlintide.AAPS PharmSciTech. 2000; 1 (1) article 6 http:\/\/www.pharmscitech.com.","journal-title":"AAPS PharmSciTech."},{"key":"121_CR10","volume-title":"Stability of Protein Pharmaceuticals. Part A. Chemical and Physical Pathways of Protein Degradation","year":"1992","unstructured":"Ahern TJ, Manning MC, eds.Stability of Protein Pharmaceuticals. Part A. Chemical and Physical Pathways of Protein Degradation. New York, NY: Plenum Press: 1992."},{"key":"121_CR11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1023\/A:1015929109894","volume":"6","author":"MC Manning","year":"1989","unstructured":"Manning MC, Patel K, Borchardt RT. Stability of protein pharmaceuticals.Pharm Res. 1989;6: 903\u2013917.","journal-title":"Pharm Res."},{"key":"121_CR12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1023\/A:1015999012852","volume":"7","author":"K Patel","year":"1990","unstructured":"Patel K, Borchardt RT. Chemical pathways of degradation III. Effect of primary sequence on the pathways of deamidation of asparaginyl residues in hexapeptides.Pharm Res. 1990;7:787\u2013793.","journal-title":"Pharm Res."},{"key":"121_CR13","first-page":"234","volume":"4","author":"S Capasso","year":"1991","unstructured":"Capasso S, Mazzarella L, Zagari A. Deamidation via cyclic imide of asparaginyl peptides: dependence on salts. buffers, and organic solvents.Peptide Res. 1991;4:234\u2013241.","journal-title":"Peptide Res."},{"key":"121_CR14","doi-asserted-by":"crossref","first-page":"8156","DOI":"10.1021\/ja00805a032","volume":"85","author":"AB Robinson","year":"1973","unstructured":"Robinson AB, Scotchler JW, McKerrow JM. Rates of nonenzymatic deamidation of glutaminyl and asparaginyl residues in pentapeptides.J Am Chem Soc. 1973;85:8156\u20138159.","journal-title":"J Am Chem Soc."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/pt010207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/pt010207\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/pt010207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:41:59Z","timestamp":1559619719000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/pt010207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["121"],"URL":"https:\/\/doi.org\/10.1208\/pt010207","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}